many patients in clinical trials
advanced hiv disease
trimetrexate-associated side effects
underlying
underlying medical conditions
clinical trial
patients in the trimetrexate-leucovorin group
discontinued treatment
side effects
sulfamethoxazole-trimethoprim group
hematologic toxicity
primary dose-limiting adverse effect
clinical trial
n =-rrb- trimetrexate
active ingredient
neutrexin
myelosuppression
resulting in neutropenia
mm
thrombocytopenia
mm
anemia
hgb
< g/dl
patients
leucovorin
therapy
patients
hematologic toxicity
renal toxicity
elevations in serum creatinine
times
upper normal limits
clinical trial patients
trimetrexate
active ingredient
neutrexin
leucovorin
gastrointestinal side effects
trimetrexate
active ingredient
neutrexin
nausea
vomiting
patients
leucovorin
mucositis
diarrhea
hepatic side effects
transient elevations in liver function tests
n =-rrb- of trial patients
leucovorin with increases
times
upper normal limits in ast
alt
alkaline phosphatase
times
upper normal limit increases in bilirubin
discontinuation of therapy
cases
hypersensitivity reactions
trimetrexate
active ingredient
neutrexin
skin rash
pruritus
severe reactions
bronchospasm
hypotension
rigors
fever
respiratory side effects
dyspnea
rare cases of pneumonitis
metabolic abnormalities
hyponatremia
hypocalcemia
dermatologic side effects
alopecia in a few patients
trimetrexate
active ingredient
neutrexin
nervous system
side effects
confusion
fatigue
side effects of neutrexin
fda
healthcare professional for medical advice